ID: ALA5204513

Max Phase: Preclinical

Molecular Formula: C18H24ClN3O

Molecular Weight: 333.86

Associated Items:

Representations

Canonical SMILES:  Cc1cc(-c2cc(Cl)c(OC[C@@](C)(N)CC(C)C)cn2)ccn1

Standard InChI:  InChI=1S/C18H24ClN3O/c1-12(2)9-18(4,20)11-23-17-10-22-16(8-15(17)19)14-5-6-21-13(3)7-14/h5-8,10,12H,9,11,20H2,1-4H3/t18-/m0/s1

Standard InChI Key:  XWZJJCICBZFART-SFHVURJKSA-N

Associated Targets(Human)

Adaptor-associated kinase 1053 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytochrome P450 3A4 53859 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

BMP-2-inducible protein kinase 723 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase-interacting serine/threonine-protein kinase MNK1 2071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Citron Rho-interacting kinase 570 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

AP2-associated protein kinase 1 50 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 333.86Molecular Weight (Monoisotopic): 333.1608AlogP: 4.25#Rotatable Bonds: 6
Polar Surface Area: 61.03Molecular Species: BASEHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.80CX LogP: 3.30CX LogD: 0.99
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.86Np Likeness Score: -0.64

References

1. Luo G, Chen L, Kostich WA, Hamman B, Allen J, Easton A, Bourin C, Gulianello M, Lippy J, Nara S, Pattipati SN, Dandapani K, Dokania M, Vattikundala P, Sharma V, Elavazhagan S, Verma MK, Lal Das M, Wagh S, Balakrishnan A, Johnson BM, Santone KS, Thalody G, Denton R, Saminathan H, Holenarsipur VK, Kumar A, Rao A, Putlur SP, Sarvasiddhi SK, Shankar G, Louis JV, Ramarao M, Conway CM, Li YW, Pieschl R, Tian Y, Hong Y, Bristow L, Albright CF, Bronson JJ, Macor JE, Dzierba CD..  (2022)  Discovery and Optimization of Biaryl Alkyl Ethers as a Novel Class of Highly Selective, CNS-Penetrable, and Orally Active Adaptor Protein-2-Associated Kinase 1 (AAK1) Inhibitors for the Potential Treatment of Neuropathic Pain.,  65  (6.0): [PMID:35261239] [10.1021/acs.jmedchem.1c02132]

Source